Market Recap For December 21st, 2022 Stocks rallied on Wednesday, following through on the slight bounce off 3800 from the previous two days. Unless the S&P completely reverses course, which is certainly possible, the benchmark should make a...
Read More
Yesterday, I hosted a webinar that took a deep dive into the philosophy and strategies used for every trade made by Options360, which have generated an average return of 56% annually, over the past 8 years. While the bulk of the session was spent...
Read More
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Take a look at the 6-month chart of DexCom (DXCM) below...
Read More
Market Recap For December 20th, 2022 The S&P tested the 3800 mark once again, and once again, that level held. As long as the benchmark index continues to do so, a run to 3900 is still on the table. When it comes to the S&P, the eventual...
Read More